复星医药(02196)获控股股东上海复星高科技解除质押1.03亿股A股及质押3200万股

Core Viewpoint - Fosun Pharma (02196) announced that its controlling shareholder, Fosun High Technology Group Co., Ltd., has pledged and released part of its A-share holdings in the company [1] Group 1 - The number of pledged shares is 32 million, which accounts for 3.33% of the shares held by the controlling shareholder and 1.20% of the total shares of the company [1] - The controlling shareholder released 103 million shares from pledge on January 22, 2026, with 476 million shares remaining pledged [1]